Bridger Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-286,002
Closed -$58.6M 39
2017
Q3
$58.6M Buy
286,002
+63,106
+28% +$14.7M 3.51% 12
2017
Q2
$54.2M Sell
222,896
-56,903
-20% -$13.4M 3.09% 12
2017
Q1
$66.8M Sell
279,799
-40,672
-13% -$9.47M 3.81% 8
2016
Q4
$67.3M Buy
+320,471
New +$66.4M 4.68% 5
2015
Q3
Sell
-207,322
Closed -$62.9M 50
2015
Q2
$62.9M Sell
207,322
-27,240
-12% -$8.12M 1.99% 8
2015
Q1
$69.8M Hold
234,562
4.67% 5
2014
Q4
$60.4M Buy
+234,562
New +$58.6M 3.8% 7

Other funds holding AGN

Bridger Management's AGN Position: Q4 2017 in Review

Bridger Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 286,002 shares — an estimated $58.6M sold.

Bridger Management first reported a position in AGN in Q4 2014 and held it in 7 quarters. The position peaked at $69.8M in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Bridger Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Bridger Management sold 286,002 Allergan plc shares in Q4 2017, an estimated $58.6M.
  • Bridger Management first reported a position in Allergan plc in Q4 2014 and held it in 7 quarters.
  • Bridger Management's Allergan plc position peaked at $69.8M in Q1 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Bridger Management's 13F filing for Q4 2017, filed 14 Feb 2018.